| mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.07 |
| mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.09 |
0.07 |
| mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.08 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.053 |
0.08 |
| mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.08 |
| mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.08 |
| mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.08 |
| mRNA |
Epothilone B |
GDSC1000 |
pan-cancer |
AAC |
-0.063 |
0.08 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.08 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.08 |